Skip to main content

Table 1 Description of patient samples used for IHC analysis

From: A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer

Sample no. Diagnosis FIGO stage Age Pre-operative CA125 Survival
Normal      
1 Normal ovarian epithelium - NA - -
2 Normal ovarian epithelium - 61 - -
3 Normal ovarian epithelium - 69 - -
4 Normal ovarian epithelium - 65 - -
5 Normal ovarian epithelium - 62 - -
6 Normal ovarian epithelium - NA - -
Borderline      
1 Serous cystadenocarcinoma Ib 50 12 4 years 10 months ALC
2 Serous cystadenocarcinoma Ic 31 117 4 years 9 monthsa
3 Serous cystadenoma Ia 60 1237 5 years ALC
4 Serous cystadenoma Ic 32 34 4 years 8 monthsa
5 Papillary serous cystadenocarcinoma Ia 47 NA 5 years 8 months ALC
Grade 2      
1 Papillary serous cystadenocarcinoma IIIc 71 NA 8 months ALC
2 Papillary serous cystadenocarcinoma IIIc 43 428 3 years 7 months until death
3 Papillary serous cystadenocarcinoma IIIc 52 309 10 months ALC
4 Papillary serous cystadenocarcinoma IV 58 3187 6 years 1 months ALC
5 Papillary serous cystadenocarcinoma IIIc 41 NA 8 years 8 monthsa
6 Serous cystadenoma NOS IIIc 49 463 2 years 7 monthsa
7 Serous cystadenoma NOS IIIa 64 1404 7 months ALC
Grade 3      
1 Papillary serous cystadenoma IIIc 75 1443 4 yrsa
2 Papillary serous cystadenocarcinoma IIc 67 24 2 months ALC
3 Serous cystadenocarcinoma NOS IIIc 55 3025 2 years 5 months until death
4 Serous cystadenocarcinoma NOS IIIc 59 4224 1 year 4 months until death
5 Serous cystadenocarcinoma NOS IIIc 76 130 3 years 6 monthsa
6 Serous cystadenocarcinoma NOS IIc 60 107 3 years 6 monthsa
7 Serous cystadenocarcinoma NOS IIIc 42 264 10 months until death
8 Serous cystadenocarcinoma NOS IIIc 58 490 2 years 8 monthsa
  1. NOS Not Otherwise Specified, ALC At Last Contact
  2. aindicates patients were alive at the time of manuscript preparation